{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T02:36:56Z","timestamp":1780454216616,"version":"3.54.1"},"reference-count":65,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2024,3,21]],"date-time":"2024-03-21T00:00:00Z","timestamp":1710979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,3,21]],"date-time":"2024-03-21T00:00:00Z","timestamp":1710979200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81570612"],"award-info":[{"award-number":["81570612"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81870497"],"award-info":[{"award-number":["81870497"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013058","name":"Jiangsu Provincial Key Research and Development Program","doi-asserted-by":"publisher","award":["BE2021737"],"award-info":[{"award-number":["BE2021737"]}],"id":[{"id":"10.13039\/501100013058","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Nanjing Health and Scientific Technology Development Program","award":["YKK20237"],"award-info":[{"award-number":["YKK20237"]}]},{"name":"Nanjing Health and Scientific Technology Development Program","award":["YKK21268"],"award-info":[{"award-number":["YKK21268"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nephrol"],"DOI":"10.1007\/s40620-024-01909-8","type":"journal-article","created":{"date-parts":[[2024,3,21]],"date-time":"2024-03-21T08:02:07Z","timestamp":1711008127000},"page":"851-863","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["SNF472: a novel therapeutic agent for vascular calcification and calciphylaxis"],"prefix":"10.1093","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8326-7602","authenticated-orcid":false,"given":"Canlin","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4297-819X","authenticated-orcid":false,"given":"Zhiyuan","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2115-6157","authenticated-orcid":false,"given":"Wen","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0235-7754","authenticated-orcid":false,"given":"Jie","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0433-4636","authenticated-orcid":false,"given":"Xiaoliang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,3,21]]},"reference":[{"issue":"10225","key":"1909_CR1","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/S0140-6736(20)30045-3","volume":"395","author":"GBD Chronic Kidney Disease Collaboration","year":"2020","unstructured":"GBD Chronic Kidney Disease Collaboration (2020) Global, regional, and national burden of chronic kidney disease, 1990\u20132017: a systematic analysis for the Global Burden of Disease Study 2017. The Lancet 395(10225):709\u2013733. https:\/\/doi.org\/10.1016\/S0140-6736(20)30045-3","journal-title":"The Lancet"},{"issue":"11","key":"1909_CR2","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1161\/CIRCULATIONAHA.120.050686","volume":"143","author":"J Jankowski","year":"2021","unstructured":"Jankowski J, Floege J, Fliser D, B\u00f6hm M, Marx N (2021) Cardiovascular disease in chronic kidney disease: pathophysiological insights and therapeutic options. Circulation 143(11):1157\u20131172. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.120.050686","journal-title":"Circulation"},{"issue":"10","key":"1909_CR3","doi-asserted-by":"publisher","first-page":"2504","DOI":"10.1681\/ASN.2014070714","volume":"26","author":"S Thompson","year":"2015","unstructured":"Thompson S, James M, Wiebe N, Hemmelgarn B, Manns B, Klarenbach S et al (2015) Cause of death in patients with reduced kidney function. J Am Soc Nephrol 26(10):2504\u20132511. https:\/\/doi.org\/10.1681\/ASN.2014070714","journal-title":"J Am Soc Nephrol"},{"issue":"18","key":"1909_CR4","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1056\/NEJMra1505292","volume":"378","author":"SU Nigwekar","year":"2018","unstructured":"Nigwekar SU, Thadhani R, Brandenburg VM (2018) Calciphylaxis. N Engl J Med 378(18):1704\u20131714. https:\/\/doi.org\/10.1056\/NEJMra1505292","journal-title":"N Engl J Med"},{"issue":"10","key":"1909_CR5","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1016\/j.mayocp.2016.06.025","volume":"91","author":"JT Mccarthy","year":"2016","unstructured":"Mccarthy JT, El-Azhary RA, Patzelt MT, Weaver AL, Albright RC, Bridges AD et al (2016) Survival, risk factors, and effect of treatment in 101 patients with calciphylaxis. Mayo Clin Proc 91(10):1384\u20131394. https:\/\/doi.org\/10.1016\/j.mayocp.2016.06.025","journal-title":"Mayo Clin Proc"},{"issue":"11","key":"1909_CR6","doi-asserted-by":"publisher","first-page":"3421","DOI":"10.1681\/ASN.2015091065","volume":"27","author":"SU Nigwekar","year":"2016","unstructured":"Nigwekar SU, Zhao S, Wenger J, Hymes JL, Maddux FW, Thadhani RI et al (2016) A nationally representative study of calcific uremic arteriolopathy risk factors. J Am Soc Nephrol 27(11):3421\u20133429. https:\/\/doi.org\/10.1681\/ASN.2015091065","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"1909_CR7","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.jacbts.2020.02.002","volume":"5","author":"AJ Nelson","year":"2020","unstructured":"Nelson AJ, Raggi P, Wolf M, Gold AM, Chertow GM, Roe MT (2020) Targeting vascular calcification in chronic kidney disease. JACC Basic Transl Sci 5(4):398\u2013412. https:\/\/doi.org\/10.1016\/j.jacbts.2020.02.002","journal-title":"JACC Basic Transl Sci"},{"issue":"6","key":"1909_CR8","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.13018","volume":"54","author":"L Wang","year":"2021","unstructured":"Wang L, Tang R, Zhang Y, Chen S, Guo Y, Wang X et al (2021) PTH-induced EndMT via miR-29a-5p\/GSAP\/Notch1 pathway contributed to valvular calcification in rats with CKD. Cell Proliferat 54(6):e13018. https:\/\/doi.org\/10.1111\/cpr.13018","journal-title":"Cell Proliferat"},{"issue":"22","key":"1909_CR9","doi-asserted-by":"publisher","first-page":"2938","DOI":"10.1161\/CIRCULATIONAHA.107.743161","volume":"117","author":"LL Demer","year":"2008","unstructured":"Demer LL, Tintut Y (2008) Vascular calcification: pathobiology of a multifaceted disease. Circulation 117(22):2938\u20132948. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.107.743161","journal-title":"Circulation"},{"issue":"2","key":"1909_CR10","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1681\/ASN.2007080854","volume":"19","author":"SM Moe","year":"2008","unstructured":"Moe SM, Chen NX (2008) Mechanisms of vascular calcification in chronic kidney disease. J Am Soc Nephrol 19(2):213\u2013216. https:\/\/doi.org\/10.1681\/ASN.2007080854","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"1909_CR11","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1111\/joim.12605","volume":"281","author":"M Tesauro","year":"2017","unstructured":"Tesauro M, Mauriello A, Rovella V, Annicchiarico-Petruzzelli M, Cardillo C, Melino G et al (2017) Arterial ageing: from endothelial dysfunction to vascular calcification. J Intern Med 281(5):471\u2013482. https:\/\/doi.org\/10.1111\/joim.12605","journal-title":"J Intern Med"},{"issue":"8564","key":"1909_CR12","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/s0140-6736(87)91370-5","volume":"2","author":"ER Maher","year":"1987","unstructured":"Maher ER, Young G, Smyth-Walsh B, Pugh S, Curtis JR (1987) Aortic and mitral valve calcification in patients with end-stage renal disease. Lancet 2(8564):875\u2013877. https:\/\/doi.org\/10.1016\/s0140-6736(87)91370-5","journal-title":"Lancet"},{"issue":"12","key":"1909_CR13","doi-asserted-by":"publisher","first-page":"2968","DOI":"10.1093\/ndt\/gft310","volume":"28","author":"M Rattazzi","year":"2013","unstructured":"Rattazzi M, Bertacco E, Del Vecchio A, Puato M, Faggin E, Pauletto P (2013) Aortic valve calcification in chronic kidney disease. Nephrol Dial Transplant 28(12):2968\u20132976. https:\/\/doi.org\/10.1093\/ndt\/gft310","journal-title":"Nephrol Dial Transplant"},{"issue":"5","key":"1909_CR14","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1097\/01.Asw.0000554443.14002.13","volume":"32","author":"JJ Chang","year":"2019","unstructured":"Chang JJ (2019) Calciphylaxis: diagnosis, pathogenesis, and treatment. Adv Skin Wound Care 32(5):205\u2013215. https:\/\/doi.org\/10.1097\/01.Asw.0000554443.14002.13","journal-title":"Adv Skin Wound Care"},{"key":"1909_CR15","doi-asserted-by":"publisher","DOI":"10.3390\/nu13051670","author":"K Tsuchiya","year":"2021","unstructured":"Tsuchiya K, Akihisa T (2021) the importance of phosphate control in chronic kidney disease. Nutrients. https:\/\/doi.org\/10.3390\/nu13051670","journal-title":"Nutrients"},{"issue":"5","key":"1909_CR16","doi-asserted-by":"publisher","first-page":"800","DOI":"10.2215\/CJN.10221014","volume":"10","author":"J Floege","year":"2015","unstructured":"Floege J, Kubo Y, Floege A, Chertow GM, Parfrey PS (2015) The effect of cinacalcet on calcific uremic arteriolopathy events in patients receiving hemodialysis: the EVOLVE Trial. Clin J Am Soc Nephrol 10(5):800\u2013807. https:\/\/doi.org\/10.2215\/CJN.10221014","journal-title":"Clin J Am Soc Nephrol"},{"issue":"2","key":"1909_CR17","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1093\/ndt\/gfr375","volume":"27","author":"WC O'Neill","year":"2012","unstructured":"O\u2019Neill WC, Hardcastle KI (2012) The chemistry of thiosulfate and vascular calcification. Nephrol Dial Transplant 27(2):521\u2013526. https:\/\/doi.org\/10.1093\/ndt\/gfr375","journal-title":"Nephrol Dial Transplant"},{"issue":"12","key":"1909_CR18","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1038\/ki.2012.322","volume":"82","author":"WL Lau","year":"2012","unstructured":"Lau WL, Leaf EM, Hu MC, Takeno MM, Kuro-O M, Moe OW et al (2012) Vitamin D receptor agonists increase klotho and osteopontin while decreasing aortic calcification in mice with chronic kidney disease fed a high phosphate diet. Kidney Int 82(12):1261\u20131270. https:\/\/doi.org\/10.1038\/ki.2012.322","journal-title":"Kidney Int"},{"key":"1909_CR19","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1186\/1471-2369-15-130","volume":"15","author":"D Hansen","year":"2014","unstructured":"Hansen D, Rasmussen K, Rasmussen LM, Bruunsgaard H, Brandi L (2014) The influence of vitamin D analogs on calcification modulators, N-terminal pro-B-type natriuretic peptide and inflammatory markers in hemodialysis patients: a randomized crossover study. BMC Nephrol 15:130. https:\/\/doi.org\/10.1186\/1471-2369-15-130","journal-title":"BMC Nephrol"},{"issue":"1","key":"1909_CR20","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1681\/ASN.2013010103","volume":"25","author":"AY Wang","year":"2014","unstructured":"Wang AY, Fang F, Chan J, Wen YY, Qing S, Chan IH et al (2014) Effect of paricalcitol on left ventricular mass and function in CKD\u2013the OPERA trial. J Am Soc Nephrol 25(1):175\u2013186. https:\/\/doi.org\/10.1681\/ASN.2013010103","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"1909_CR21","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1001\/2013.jamadermatol.5","volume":"149","author":"RA El-Azhary","year":"2013","unstructured":"El-Azhary RA, Arthur AK, Davis MDP, Mcevoy MT, Gibson LE, Weaver AL et al (2013) Retrospective analysis of tissue plasminogen activator as an adjuvant treatment for calciphylaxis. Jama Dermatol 149(1):63\u201367. https:\/\/doi.org\/10.1001\/2013.jamadermatol.5","journal-title":"Jama Dermatol"},{"issue":"4","key":"1909_CR22","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1093\/ckj\/sfx126","volume":"11","author":"D Christiadi","year":"2018","unstructured":"Christiadi D, Singer RF (2018) Calciphylaxis in a dialysis patient successfully treated with high-dose vitamin K supplementation. Clin Kidney J 11(4):528\u2013529. https:\/\/doi.org\/10.1093\/ckj\/sfx126","journal-title":"Clin Kidney J"},{"key":"1909_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejim.2020.05.032","volume":"79","author":"M Marietta","year":"2020","unstructured":"Marietta M, Coluccio V, Boriani G, Luppi M (2020) Effects of Anti-vitamin k oral anticoagulants on bone and cardiovascular health. Eur J Intern Med 79:1\u201311. https:\/\/doi.org\/10.1016\/j.ejim.2020.05.032","journal-title":"Eur J Intern Med"},{"issue":"6","key":"1909_CR24","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1038\/ki.2008.646","volume":"75","author":"KA Lomashvili","year":"2009","unstructured":"Lomashvili KA, Monier-Faugere MC, Wang X, Malluche HH, O\u2019Neill WC (2009) Effect of bisphosphonates on vascular calcification and bone metabolism in experimental renal failure. Kidney Int 75(6):617\u2013625. https:\/\/doi.org\/10.1038\/ki.2008.646","journal-title":"Kidney Int"},{"key":"1909_CR25","doi-asserted-by":"publisher","DOI":"10.2741\/1786","author":"F Grases","year":"2006","unstructured":"Grases F (2006) Phytate (Myo-inositol hexakisphosphate) inhibits cardiovascular calcifications in rats. Front Biosci. https:\/\/doi.org\/10.2741\/1786","journal-title":"Front Biosci"},{"issue":"3","key":"1909_CR26","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.carpath.2007.08.005","volume":"17","author":"F Grases","year":"2008","unstructured":"Grases F, Sanchis P, Costa-Bauz\u00e1 A, Bonnin O, Isern B, Perell\u00f3 J et al (2008) Phytate inhibits bovine pericardium calcification in vitro. Cardiovasc Pathol 17(3):139\u2013145. https:\/\/doi.org\/10.1016\/j.carpath.2007.08.005","journal-title":"Cardiovasc Pathol"},{"issue":"4","key":"1909_CR27","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1053\/j.jrn.2016.01.010","volume":"26","author":"P Sanchis","year":"2016","unstructured":"Sanchis P, Buades JM, Berga F, Gelabert MM, Molina M, \u00ed\u00f1igo MV et al (2016) Protective effect of myo-inositol hexaphosphate (Phytate) on abdominal aortic calcification in patients with chronic kidney disease. J Ren Nutr 26(4):226\u2013236. https:\/\/doi.org\/10.1053\/j.jrn.2016.01.010","journal-title":"J Ren Nutr"},{"issue":"1","key":"1909_CR28","doi-asserted-by":"publisher","first-page":"6858","DOI":"10.1038\/s41598-017-07203-x","volume":"7","author":"MD Ferrer","year":"2017","unstructured":"Ferrer MD, P\u00e9rez MM, C\u00e0naves MM, Buades JM, Salcedo C, Perell\u00f3 J (2017) A novel pharmacodynamic assay to evaluate the effects of crystallization inhibitors on calcium phosphate crystallization in human plasma. Sci Rep-UK 7(1):6858. https:\/\/doi.org\/10.1038\/s41598-017-07203-x","journal-title":"Sci Rep-UK"},{"issue":"12","key":"1909_CR29","doi-asserted-by":"publisher","first-page":"2867","DOI":"10.1111\/bcp.13752","volume":"84","author":"J Perell\u00f3","year":"2018","unstructured":"Perell\u00f3 J, Joubert PH, Ferrer MD, Canals AZ, Sinha S, Salcedo C (2018) First-time-in-human randomized clinical trial in healthy volunteers and haemodialysis patients with SNF472, a novel inhibitor of vascular calcification. Br J Clin Pharmacol 84(12):2867\u20132876. https:\/\/doi.org\/10.1111\/bcp.13752","journal-title":"Br J Clin Pharmacol"},{"issue":"19","key":"1909_CR30","doi-asserted-by":"publisher","first-page":"4400","DOI":"10.1111\/bph.15163","volume":"177","author":"J Perell\u00f3","year":"2020","unstructured":"Perell\u00f3 J, Ferrer MD, Del MPM, Kaesler N, Brandenburg VM, Behets GJ et al (2020) Mechanism of action of SNF472, a novel calcification inhibitor to treat vascular calcification and calciphylaxis. Br J Pharmacol 177(19):4400\u20134415. https:\/\/doi.org\/10.1111\/bph.15163","journal-title":"Br J Pharmacol"},{"issue":"5","key":"1909_CR31","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0197061","volume":"13","author":"MD Ferrer","year":"2018","unstructured":"Ferrer MD, Ketteler M, Tur F, Tur E, Isern B, Salcedo C et al (2018) Characterization of SNF472 pharmacokinetics and efficacy in uremic and non-uremic rats models of cardiovascular calcification. PLoS One 13(5):e197061. https:\/\/doi.org\/10.1371\/journal.pone.0197061","journal-title":"PLoS One"},{"key":"1909_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.vph.2019.106583","volume":"122\u2013123","author":"A Zabirnyk","year":"2019","unstructured":"Zabirnyk A, Ferrer MD, Bogdanova M, P\u00e9rez MM, Salcedo C, Kaljusto ML et al (2019) SNF472, a novel anti-crystallization agent, inhibits induced calcification in an in vitro model of human aortic valve calcification. Vascul Pharmacol 122\u2013123:106583. https:\/\/doi.org\/10.1016\/j.vph.2019.106583","journal-title":"Vascul Pharmacol"},{"key":"1909_CR33","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.568764","volume":"11","author":"A Zabirnyk","year":"2020","unstructured":"Zabirnyk A, Perez MDM, Blasco M, Stensl\u00f8kken K, Ferrer MD, Salcedo C et al (2020) A novel ex vivo model of aortic valve calcification. A preliminary report. Front Pharmacol 11:568764. https:\/\/doi.org\/10.3389\/fphar.2020.568764","journal-title":"Front Pharmacol"},{"issue":"4","key":"1909_CR34","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1111\/bcp.13863","volume":"85","author":"C Salcedo","year":"2019","unstructured":"Salcedo C, Joubert PH, Ferrer MD, Canals AZ, Maduell F, Torregrosa V et al (2019) A phase 1b randomized, placebo-controlled clinical trial with SNF472 in haemodialysis patients. Br J Clin Pharmacol 85(4):796\u2013806. https:\/\/doi.org\/10.1111\/bcp.13863","journal-title":"Br J Clin Pharmacol"},{"issue":"7","key":"1909_CR35","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1093\/jn\/110.7.1458","volume":"110","author":"A Nahapetian","year":"1980","unstructured":"Nahapetian A, Young VR (1980) Metabolism of 14C-phytate in rats: effect of low and high dietary calcium intakes. J Nutr 110(7):1458\u20131472. https:\/\/doi.org\/10.1093\/jn\/110.7.1458","journal-title":"J Nutr"},{"issue":"4","key":"1909_CR36","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/s0735-1097(01)01781-8","volume":"39","author":"P Raggi","year":"2002","unstructured":"Raggi P, Boulay A, Chasan-Taber S, Amin N, Dillon M, Burke SK et al (2002) Cardiac calcification in adult hemodialysis patients. A link between end-stage renal disease and cardiovascular disease? J Am Coll Cardiol 39(4):695\u2013701. https:\/\/doi.org\/10.1016\/s0735-1097(01)01781-8","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"1909_CR37","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.atherosclerosis.2014.12.040","volume":"239","author":"K Alluri","year":"2015","unstructured":"Alluri K, Joshi PH, Henry TS, Blumenthal RS, Nasir K, Blaha MJ (2015) Scoring of coronary artery calcium scans: history, assumptions, current limitations, and future directions. Atherosclerosis 239(1):109\u2013117. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2014.12.040","journal-title":"Atherosclerosis"},{"issue":"1","key":"1909_CR38","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1093\/ckj\/sfz144","volume":"14","author":"A Bellasi","year":"2021","unstructured":"Bellasi A, Raggi P, Bover J, Bushinsky DA, Chertow GM, Ketteler M et al (2021) Trial design and baseline characteristics of CaLIPSO: a randomized, double-blind placebo-controlled trial of SNF472 in patients receiving haemodialysis with cardiovascular calcification. Clin Kidney J 14(1):366\u2013374. https:\/\/doi.org\/10.1093\/ckj\/sfz144","journal-title":"Clin Kidney J"},{"issue":"9","key":"1909_CR39","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1161\/CIRCULATIONAHA.119.044195","volume":"141","author":"P Raggi","year":"2020","unstructured":"Raggi P, Bellasi A, Bushinsky D, Bover J, Rodriguez M, Ketteler M et al (2020) Slowing progression of cardiovascular calcification with SNF472 in patients on hemodialysis: results of a randomized phase 2b study. Circulation 141(9):728\u2013739. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.119.044195","journal-title":"Circulation"},{"issue":"12","key":"1909_CR40","doi-asserted-by":"publisher","first-page":"2178","DOI":"10.1016\/j.ekir.2020.09.032","volume":"5","author":"P Raggi","year":"2020","unstructured":"Raggi P, Bellasi A, Sinha S, Bover J, Rodriguez M, Ketteler M et al (2020) Effects of SNF472, a novel inhibitor of hydroxyapatite crystallization in patients receiving hemodialysis\u2014subgroup analyses of the CALIPSO Trial. Kidney Int Rep 5(12):2178\u20132182. https:\/\/doi.org\/10.1016\/j.ekir.2020.09.032","journal-title":"Kidney Int Rep"},{"issue":"5","key":"1909_CR41","doi-asserted-by":"publisher","first-page":"736","DOI":"10.2215\/cjn.16931020","volume":"16","author":"DA Bushinsky","year":"2021","unstructured":"Bushinsky DA, Raggi P, Bover J, Ketteler M, Bellasi A, Rodriguez M et al (2021) Effects of myo-inositol hexaphosphate (SNF472) on bone mineral density in patients receiving hemodialysis: an analysis of the randomized, placebo-controlled CaLIPSO Study. Clin J Am Soc Nephrol 16(5):736\u2013745. https:\/\/doi.org\/10.2215\/cjn.16931020","journal-title":"Clin J Am Soc Nephrol"},{"issue":"Suppl 3","key":"1909_CR42","doi-asserted-by":"publisher","first-page":"S724","DOI":"10.1007\/s11606-014-2910-1","volume":"29 Suppl 3","author":"SU Nigwekar","year":"2014","unstructured":"Nigwekar SU, Solid CA, Ankers E, Malhotra R, Eggert W, Turchin A et al (2014) Quantifying a rare disease in administrative data: the example of calciphylaxis. J Gen Intern Med 29 Suppl 3(Suppl 3):S724\u2013S731. https:\/\/doi.org\/10.1007\/s11606-014-2910-1","journal-title":"J Gen Intern Med"},{"issue":"1","key":"1909_CR43","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1093\/ndt\/gfv438","volume":"32","author":"VM Brandenburg","year":"2017","unstructured":"Brandenburg VM, Kramann R, Rothe H, Kaesler N, Korbiel J, Specht P et al (2017) Calcific uraemic arteriolopathy (calciphylaxis): data from a large nationwide registry. Nephrol Dial Transplant 32(1):126\u2013132. https:\/\/doi.org\/10.1093\/ndt\/gfv438","journal-title":"Nephrol Dial Transplant"},{"key":"1909_CR44","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.902171","volume":"9","author":"Y Liu","year":"2022","unstructured":"Liu Y, Yang C, Yang X, Xie X, Liu H, Zhang L et al (2022) Prevalence and clinical characteristics of calciphylaxis in chinese hemodialysis patients. Front Med (Lausanne) 9:902171. https:\/\/doi.org\/10.3389\/fmed.2022.902171","journal-title":"Front Med (Lausanne)"},{"issue":"1(B)","key":"1909_CR45","doi-asserted-by":"publisher","first-page":"367","DOI":"10.47391\/JPMA.1244","volume":"71","author":"C Yang","year":"2021","unstructured":"Yang C, Liu Y, Ni H, Li X, Liu H, Zhang X (2021) Potential effect of sodium thiosulfate in calciphylaxis: remission of intractable pain. J Pak Med Assoc 71(1(B)):367\u2013369. https:\/\/doi.org\/10.47391\/JPMA.1244","journal-title":"J Pak Med Assoc"},{"issue":"2","key":"1909_CR46","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1053\/gast.2002.31387","volume":"122","author":"J Rivera-Nieves","year":"2002","unstructured":"Rivera-Nieves J, Bamias G, Alfert J, Bickston SJ, Moskaluk CA, Cominelli F (2002) Intestinal ischemia and peripheral gangrene in a patient with chronic renal failure. Gastroenterology 122(2):495\u2013499. https:\/\/doi.org\/10.1053\/gast.2002.31387","journal-title":"Gastroenterology"},{"issue":"5","key":"1909_CR47","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1007\/s40620-021-01121-y","volume":"34","author":"W Shi","year":"2021","unstructured":"Shi W, Xie X, Liu Y, Yang C, Zhang X (2021) The mystery of black lungs in a patient with calciphylaxis. J Nephrol 34(5):1553\u20131555. https:\/\/doi.org\/10.1007\/s40620-021-01121-y","journal-title":"J Nephrol"},{"issue":"11","key":"1909_CR48","doi-asserted-by":"publisher","first-page":"4617","DOI":"10.21037\/qims-20-1211","volume":"11","author":"Q Yu","year":"2021","unstructured":"Yu Q, Liu Y, Xie X, Liu J, Huang S, Zhang X et al (2021) Radiomics-based method for diagnosis of calciphylaxis in patients with chronic kidney disease using computed tomography. Quant Imag Med Surg 11(11):4617\u20134626. https:\/\/doi.org\/10.21037\/qims-20-1211","journal-title":"Quant Imag Med Surg"},{"issue":"5","key":"1909_CR49","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1016\/j.kint.2022.01.020","volume":"101","author":"C Yang","year":"2022","unstructured":"Yang C, Zhang X, Xie X, Zhao Y (2022) Comments on \u201cUltrasound findings of calciphylaxis.\u201d Kidney Int 101(5):1085. https:\/\/doi.org\/10.1016\/j.kint.2022.01.020","journal-title":"Kidney Int"},{"key":"1909_CR50","doi-asserted-by":"publisher","DOI":"10.1111\/exd.14579","author":"X Zhu","year":"2022","unstructured":"Zhu X, Liu Y, Yang X, Liu B, Zhang X (2022) Identifying subcutaneous tissue microcalcification by Fluo-3 AM imaging in cutaneous calciphylaxis. Exp Dermatol. https:\/\/doi.org\/10.1111\/exd.14579","journal-title":"Exp Dermatol"},{"issue":"5","key":"1909_CR51","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1007\/s40620-019-00631-0","volume":"32","author":"VM Brandenburg","year":"2019","unstructured":"Brandenburg VM, Sinha S, Torregrosa JV, Garg R, Miller S, Canals AZ et al (2019) Improvement in wound healing, pain, and quality of life after 12 weeks of SNF472 treatment: a phase 2 open-label study of patients with calciphylaxis. J Nephrol 32(5):811\u2013821. https:\/\/doi.org\/10.1007\/s40620-019-00631-0","journal-title":"J Nephrol"},{"issue":"3","key":"1909_CR52","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1097\/WON.0b013e3181d73aab","volume":"37","author":"C Harris","year":"2010","unstructured":"Harris C, Bates-Jensen B, Parslow N, Raizman R, Singh M, Ketchen R (2010) Bates-Jensen wound assessment tool: pictorial guide validation project. J Wound Ostomy Continence Nurs 37(3):253\u2013259. https:\/\/doi.org\/10.1097\/WON.0b013e3181d73aab","journal-title":"J Wound Ostomy Continence Nurs"},{"issue":"6","key":"1909_CR53","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1016\/j.jpainsymman.2010.08.016","volume":"41","author":"MJ Hjermstad","year":"2011","unstructured":"Hjermstad MJ, Fayers PM, Haugen DF, Caraceni A, Hanks GW, Loge JH et al (2011) Studies comparing Numerical Rating Scales, Verbal Rating Scales, and Visual Analogue Scales for assessment of pain intensity in adults: a systematic literature review. J Pain Symptom Manage 41(6):1073\u20131093. https:\/\/doi.org\/10.1016\/j.jpainsymman.2010.08.016","journal-title":"J Pain Symptom Manage"},{"key":"1909_CR54","doi-asserted-by":"publisher","DOI":"10.1111\/iwj.14505","author":"TM Janke","year":"2023","unstructured":"Janke TM, Kozon V, Valiukeviciene S, Rackauskaite L, Reich A, St\u0119pie\u0144 K et al (2023) Validation of the Wound-QoL-17 and the Wound-QoL-14 in a European sample of 305 patients with chronic wounds. Int Wound J. https:\/\/doi.org\/10.1111\/iwj.14505","journal-title":"Int Wound J"},{"issue":"1","key":"1909_CR55","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1093\/ckj\/sfab117","volume":"15","author":"S Sinha","year":"2022","unstructured":"Sinha S, Gould LJ, Nigwekar SU, Serena TE, Brandenburg V, Moe SM et al (2022) The CALCIPHYX study: a randomized, double-blind, placebo-controlled, Phase 3 clinical trial of SNF472 for the treatment of calciphylaxis. Clin Kidney J 15(1):136\u2013144. https:\/\/doi.org\/10.1093\/ckj\/sfab117","journal-title":"Clin Kidney J"},{"key":"1909_CR56","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics11040730","author":"LJ Gould","year":"2021","unstructured":"Gould LJ, Serena TE, Sinha S (2021) Development of the BWAT-CUA scale to assess wounds in patients with calciphylaxis. Diagnostics (Basel). https:\/\/doi.org\/10.3390\/diagnostics11040730","journal-title":"Diagnostics (Basel)"},{"issue":"3","key":"1909_CR57","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1053\/ajkd.2002.34885","volume":"40","author":"Y Leskinen","year":"2002","unstructured":"Leskinen Y, Salenius JP, Lehtim\u00e4ki T, Huhtala H, Saha H (2002) The prevalence of peripheral arterial disease and medial arterial calcification in patients with chronic renal failure: requirements for diagnostics. Am J Kidney Dis 40(3):472\u2013479. https:\/\/doi.org\/10.1053\/ajkd.2002.34885","journal-title":"Am J Kidney Dis"},{"issue":"8","key":"1909_CR58","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1161\/ATVBAHA.116.306717","volume":"36","author":"CY Ho","year":"2016","unstructured":"Ho CY, Shanahan CM (2016) Medial arterial calcification: an overlooked player in peripheral arterial disease. Arterioscler Thromb Vasc Biol 36(8):1475\u20131482. https:\/\/doi.org\/10.1161\/ATVBAHA.116.306717","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"SUPPL 3","key":"1909_CR59","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfaa144.P1234","volume":"35","author":"F Bassissi","year":"2020","unstructured":"Bassissi F, Reynes MDF, P\u00e9rez MM, Perell\u00f3 J, Salcedo C (2020) SNF472 improves limb blood perfusion and walking ability in a peripheral artery disease vascular calcification rat model. Nephrol Dial Transpl 35(SUPPL 3):i265. https:\/\/doi.org\/10.1093\/ndt\/gfaa144.P1234","journal-title":"Nephrol Dial Transpl"},{"issue":"6","key":"1909_CR60","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1016\/j.kint.2017.07.021","volume":"92","author":"A Pimentel","year":"2017","unstructured":"Pimentel A, Ure\u00f1a-Torres P, Zillikens MC, Bover J, Cohen-Solal M (2017) Fractures in patients with CKD-diagnosis, treatment, and prevention: a review by members of the European Calcified Tissue Society and the European Renal Association of Nephrology Dialysis and Transplantation. Kidney Int 92(6):1343\u20131355. https:\/\/doi.org\/10.1016\/j.kint.2017.07.021","journal-title":"Kidney Int"},{"issue":"4","key":"1909_CR61","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1159\/000341474","volume":"30","author":"MM Arriero","year":"2012","unstructured":"Arriero MM, Ramis JM, Perell\u00f3 J, Monjo M (2012) Differential response of MC3T3-E1 and human mesenchymal stem cells to inositol hexakisphosphate. Cell Physiol Biochem 30(4):974\u2013986. https:\/\/doi.org\/10.1159\/000341474","journal-title":"Cell Physiol Biochem"},{"issue":"4","key":"1909_CR62","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1016\/j.bone.2010.01.367","volume":"46","author":"WN Addison","year":"2010","unstructured":"Addison WN, Mckee MD (2010) Inositol hexakisphosphate inhibits mineralization of MC3T3-E1 osteoblast cultures. Bone 46(4):1100\u20131107. https:\/\/doi.org\/10.1016\/j.bone.2010.01.367","journal-title":"Bone"},{"issue":"6","key":"1909_CR63","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1089\/jmf.2009.0152","volume":"13","author":"F Grases","year":"2010","unstructured":"Grases F, Sanchis P, Prieto RM, Perell\u00f3 J, L\u00f3pez-Gonz\u00e1lez \u00c1A (2010) Effect of tetracalcium dimagnesium phytate on bone characteristics in ovariectomized rats. J Med Food 13(6):1301\u20131306. https:\/\/doi.org\/10.1089\/jmf.2009.0152","journal-title":"J Med Food"},{"issue":"2","key":"1909_CR64","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1007\/s00394-012-0377-6","volume":"52","author":"AA L\u00f3pez-Gonz\u00e1lez","year":"2013","unstructured":"L\u00f3pez-Gonz\u00e1lez AA, Grases F, Monroy N, Mar\u00ed B, Vicente-Herrero MT, Tur F et al (2013) Protective effect of myo-inositol hexaphosphate (phytate) on bone mass loss in postmenopausal women. Eur J Nutr 52(2):717\u2013726. https:\/\/doi.org\/10.1007\/s00394-012-0377-6","journal-title":"Eur J Nutr"},{"issue":"4","key":"1909_CR65","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1089\/jmf.2008.0087","volume":"11","author":"AA L\u00f3pez-Gonz\u00e1lez","year":"2008","unstructured":"L\u00f3pez-Gonz\u00e1lez AA, Grases F, Roca P, Mari B, Vicente-Herrero MT, Costa-Bauz\u00e1 A (2008) Phytate (myo-inositol hexaphosphate) and risk factors for osteoporosis. J Med Food 11(4):747\u2013752. https:\/\/doi.org\/10.1089\/jmf.2008.0087","journal-title":"J Med Food"}],"container-title":["Journal of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-024-01909-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40620-024-01909-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-024-01909-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T15:54:02Z","timestamp":1777564442000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/joneph\/article\/37\/4\/851\/8306801"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,21]]},"references-count":65,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2024,5]]}},"alternative-id":["1909"],"URL":"https:\/\/doi.org\/10.1007\/s40620-024-01909-8","relation":{},"ISSN":["1724-6059"],"issn-type":[{"value":"1724-6059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,21]]},"assertion":[{"value":"16 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declared no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and material"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}